InMed Pharmaceuticals Inc.INMNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR+48.1%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+48.1%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
7.1x
Strong expansion
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202558.48%
202467.97%
202399.60%
2022-2173.97%
202119.14%
20208.20%
2019-22.54%
2018-27.36%
2017-25.95%
201659.56%